We are live on ! Find out more
PROK icon

ProKidney
PROK

90 hedge funds and large institutions have $227M invested in ProKidney in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

7% more funds holding

Funds holding: 84 → 90 (+6)

0% more capital invested

Capital invested by funds: $226M → $227M (+$880K)

0% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 15

0.56% less ownership

Funds ownership: 89.97% → 89.42% (-0.56%)

Holders
90
Holders Change
+6
Holders Change %
+7.14%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
15
Reduced
15
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RIA
RP Investment Advisors
Ontario, Canada
+$5.33M
2
LCM
LH Capital Markets
New York
+$4.94M
3
CAC
Cowen and Company
New York
+$3.18M
4
SC
Sculptor Capital
New York
+$1.64M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.17M

Top Sellers

Rank Fund Capital Flow
1
BCM
BlueCrest Capital Management
Jersey
-$5M
2
MS
Maven Securities
Jersey
-$4.9M
3
AC
Athanor Capital
New York
-$3.92M
4
SSA
Schonfeld Strategic Advisors
New York
-$3.92M
5
GCL
Glazer Capital LLC
New York
-$1.84M

PROK Hedge Fund Activity: Q4 2021 in Review

90 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q4 2021, worth a combined $227M — up 0.39% from $226M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new PROK positions and 7 closed out — a net gain of 6 holders — while 15 added to existing stakes and 15 trimmed.

The largest buyer was RP Investment Advisors, opening a new position worth an estimated $5.33M. The largest seller was BlueCrest Capital Management, cutting an estimated $5M.

  • 90 institutional investors held ProKidney (PROK) as of Q4 2021, up from 84 in Q3 2021.
  • Funds reported $227M of ProKidney stock for Q4 2021, up 0.39% quarter-over-quarter.
  • 13 funds opened new ProKidney positions in Q4 2021 and 7 closed out, a net change of +6 holders.
  • The largest ProKidney buyer in Q4 2021 was RP Investment Advisors, an estimated $5.33M added.
  • The largest ProKidney seller in Q4 2021 was BlueCrest Capital Management, an estimated $5M sold.

Based on aggregated 13F filings for Q4 2021.